VML Australia approached me to create a visual repreentation of the CAR-T cell.

CAR-T cell therapy is a type of immunotherapy that uses genetically modified T cells to treat certain types of cancer.

CAR stands for "chimeric antigen receptor", which is a synthetic receptor that is added to the T cells in the laboratory.

The CAR receptor is designed to recognize a specific protein (antigen) on the surface of cancer cells. Once the CAR-T cells are infused into the patient's bloodstream, they seek out and bind to the cancer cells that express the antigen on their surface. And, This binding triggers the CAR-T cells to attack and destroy the cancer cells.